Cargando…

A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease

Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Marvel, Cherie L., Alm, Kylie H., Bhattacharya, Deeya, Rebman, Alison W., Bakker, Arnold, Morgan, Owen P., Creighton, Jason A., Kozero, Erica A., Venkatesan, Arun, Nadkarni, Prianca A., Aucott, John N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604010/
https://www.ncbi.nlm.nih.gov/pubmed/36288329
http://dx.doi.org/10.1371/journal.pone.0271425
_version_ 1784817702954598400
author Marvel, Cherie L.
Alm, Kylie H.
Bhattacharya, Deeya
Rebman, Alison W.
Bakker, Arnold
Morgan, Owen P.
Creighton, Jason A.
Kozero, Erica A.
Venkatesan, Arun
Nadkarni, Prianca A.
Aucott, John N.
author_facet Marvel, Cherie L.
Alm, Kylie H.
Bhattacharya, Deeya
Rebman, Alison W.
Bakker, Arnold
Morgan, Owen P.
Creighton, Jason A.
Kozero, Erica A.
Venkatesan, Arun
Nadkarni, Prianca A.
Aucott, John N.
author_sort Marvel, Cherie L.
collection PubMed
description Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process.
format Online
Article
Text
id pubmed-9604010
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-96040102022-10-27 A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease Marvel, Cherie L. Alm, Kylie H. Bhattacharya, Deeya Rebman, Alison W. Bakker, Arnold Morgan, Owen P. Creighton, Jason A. Kozero, Erica A. Venkatesan, Arun Nadkarni, Prianca A. Aucott, John N. PLoS One Research Article Lyme disease is the most common vector-borne infectious disease in the United States. Post-treatment Lyme disease (PTLD) is a condition affecting 10–20% of patients in which symptoms persist despite antibiotic treatment. Cognitive complaints are common among those with PTLD, suggesting that brain changes are associated with the course of the illness. However, there has been a paucity of evidence to explain the cognitive difficulties expressed by patients with PTLD. This study administered a working memory task to a carefully screened group of 12 patients with well-characterized PTLD and 18 healthy controls while undergoing functional MRI (fMRI). A subset of 12 controls and all 12 PTLD participants also received diffusion tensor imaging (DTI) to measure white matter integrity. Clinical variables were also assessed and correlated with these multimodal MRI findings. On the working memory task, the patients with PTLD responded more slowly, but no less accurately, than did controls. FMRI activations were observed in expected regions by the controls, and to a lesser extent, by the PTLD participants. The PTLD group also hypoactivated several regions relevant to the task. Conversely, novel regions were activated by the PTLD group that were not observed in controls, suggesting a compensatory mechanism. Notably, three activations were located in white matter of the frontal lobe. DTI measures applied to these three regions of interest revealed that higher axial diffusivity correlated with fewer cognitive and neurological symptoms. Whole-brain DTI analyses revealed several frontal lobe regions in which higher axial diffusivity in the patients with PTLD correlated with longer duration of illness. Together, these results show that the brain is altered by PTLD, involving changes to white matter within the frontal lobe. Higher axial diffusivity may reflect white matter repair and healing over time, rather than pathology, and cognition appears to be dynamically affected throughout this repair process. Public Library of Science 2022-10-26 /pmc/articles/PMC9604010/ /pubmed/36288329 http://dx.doi.org/10.1371/journal.pone.0271425 Text en © 2022 Marvel et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Marvel, Cherie L.
Alm, Kylie H.
Bhattacharya, Deeya
Rebman, Alison W.
Bakker, Arnold
Morgan, Owen P.
Creighton, Jason A.
Kozero, Erica A.
Venkatesan, Arun
Nadkarni, Prianca A.
Aucott, John N.
A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title_full A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title_fullStr A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title_full_unstemmed A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title_short A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease
title_sort multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment lyme disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604010/
https://www.ncbi.nlm.nih.gov/pubmed/36288329
http://dx.doi.org/10.1371/journal.pone.0271425
work_keys_str_mv AT marvelcheriel amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT almkylieh amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT bhattacharyadeeya amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT rebmanalisonw amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT bakkerarnold amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT morganowenp amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT creightonjasona amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT kozeroericaa amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT venkatesanarun amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT nadkarnipriancaa amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT aucottjohnn amultimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT marvelcheriel multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT almkylieh multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT bhattacharyadeeya multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT rebmanalisonw multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT bakkerarnold multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT morganowenp multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT creightonjasona multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT kozeroericaa multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT venkatesanarun multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT nadkarnipriancaa multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease
AT aucottjohnn multimodalneuroimagingstudyofbrainabnormalitiesandclinicalcorrelatesinposttreatmentlymedisease